Lv12
30 积分 2024-03-12 加入
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
6小时前
已完结
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer
22小时前
已完结
Industry perspective on the nonclinical safety assessment of heterobifunctional degraders
1个月前
已完结
Session 5: Protein Degraders
1个月前
已完结
Streamlining nonclinical drug development using the FDA 505(b)(2) new drug application regulatory pathway
1个月前
已完结
Streamlining nonclinical drug development using the FDA 505(b)(2) new drug application regulatory pathway
2个月前
已完结
皖公网安备34019202002308
